Although it appears contradictory that ChREBP overexpression and deletion lead to decreases in ketogenesis by decreasing β-oxidation, these findings are consistent with in vivo evidence that both Chrebp gene deletion and Chrebp gene activation fail to prevent the development of high-fat diet-induced fatty liver [31,33]. Here, MLXIPL is linked to fatty liver disease.